Your browser doesn't support javascript.
loading
Efficacy of Proactive Topical Antihistamine Use in Patients with Seasonal Allergic Conjunctivitis.
Fukushima, Atsuki; Miyazaki, Dai; Kishimoto, Hirotsugu; Ebihara, Nobuyuki.
Affiliation
  • Fukushima A; Department of Ophthalmology, Saneikai Tsukazaki Hospital, 68-1 Aboshi-ku, Waku, Himeji, Hyogo, 671-1227, Japan. a.fukushima@tsukazaki-eye.net.
  • Miyazaki D; Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University, 36-1 Nishicho, Yonago, Tottori, 683-8504, Japan. miyazaki-ttr@umin.ac.jp.
  • Kishimoto H; Japan Medical Affairs, Santen Pharmaceutical Co., Ltd., 4-20, Ofukacho, Kita-ku, Osaka, 530-8552, Japan.
  • Ebihara N; Department of Ophthalmology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu, Chiba, 279-0021, Japan.
Adv Ther ; 39(12): 5568-5581, 2022 12.
Article in En | MEDLINE | ID: mdl-36244054
INTRODUCTION: Topical antihistamines are often instilled symptomatically to control patients' eye allergy symptoms. The purpose of this study was to evaluate the effectiveness of proactive and as-needed use of antihistamine eye drops in controlling symptoms and to examine whether proactive use may improve quality of life (QOL). METHODS: This was a prospective, multicenter, cohort study in Japan. We classified 418 patients who had developed certain symptoms and used antihistamine eye drops for 2 weeks into two groups: those who used the drops at the required frequency at a fixed time (proactive use) and those who used them as-needed. The Japanese Allergic and Conjunctival Diseases Quality of Life Questionnaire (JACQLQ) and Ten-Item Personality Inventory were used to evaluate QOL and personality. Participants' QOL was evaluated using JACQLQ scores after matching of baseline characteristics using propensity score analysis. RESULTS: After propensity score matching, 115 "proactive" and 115 "as-needed" patients were analyzed. After treatment, in "as-needed" patients, the overall QOL scale was 1.66 (95% CI 1.55-1.78); in "proactive" patients, the overall QOL scale was 1.34 (95% CI 1.23-1.46) and was significantly improved compared with the "as-needed" patients (analysis of covariance, P = 0.002). Furthermore, proactive use significantly alleviated depression (P = 0.03). This improvement of QOL was independent of improvement of the clinical sign scores. CONCLUSION: Proactive use of topical antihistamine may serve as an effective means for improving QOL of patients with seasonal allergic conjunctivitis. TRIAL REGISTRATION: University Hospital Medical Information Network (UMIN) 000039554.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Conjunctivitis, Allergic Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Adv Ther Journal subject: TERAPEUTICA Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Conjunctivitis, Allergic Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Adv Ther Journal subject: TERAPEUTICA Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United States